News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Beach
Amgen Stock Direction Hinges on Bone Cancer Data
October 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LOS ANGELES, Oct 7 (Reuters) - Amgen Inc (AMGN.O) investors stand to reap significant benefits should upcoming data for the biotechnology company's drug denosumab show the medicine can prevent cancer from spreading to the bone.
Twitter
LinkedIn
Facebook
Email
Print
Amgen
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
·
3 min read
·
Greg Slabodkin
Biotech Beach
The ABCs of Biopharma This Week: ASCO, BIO and Cancer
June 5, 2024
·
1 min read
·
Greg Slabodkin, Heather McKenzie, Tyler Patchen
Business
BIO24 Kicks Off in San Diego as City’s Biotech Hub Gets Hit with Jobs Downturn
June 3, 2024
·
5 min read
·
Tyler Patchen
